Arkolith/Insider Trading/SCPH/Form 4

Nokes Rachael

CFO and TreasurerscPharmaceuticals Inc. (SCPH) · full profile →Form 4 · filed Oct 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Disposed to issuer(D)126K——0
Oct 7, 2025Tender(U)30K——126K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 7, 2025Disposed to issuer(D)14K—$00
Oct 7, 2025Disposed to issuer(D)55K—$00
Oct 7, 2025Disposed to issuer(D)133K—$00
Oct 7, 2025Disposed to issuer(D)6K—$00

Transaction Codes

D
Disposition to the issuer
U
See SEC Form 4 code table

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-233533) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML